Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic-associated fatty liver
disease (MAFLD), is one of the most common causes of liver diseases worldwide. NAFLD is …

Background Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease ranging from
simple hepatic steatosis (NAFL) to non-alcoholic steatohepatitis (NASH) which may …

Background Natural bioactive components derived from plant secondary metabolites have
been pronounced as valuable alternatives for anticipating and subsiding hepatotoxic effects …

Liver fibrosis is associated with liver-related outcomes, yet often remains underdiagnosed in
primary care settings. Hyperuricemia is associated with non-alcoholic fatty liver disease …

Nonalcoholic fatty liver disease (NAFLD) currently represents one of the most common liver
diseases worldwide. Early diagnosis and disease staging is crucial, since it is mainly …

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases. Its
incidence is progressively rising and it is possibly becoming a worldwide epidemic. NAFLD …

Context The incidence and remission of nonalcoholic fatty liver disease (NAFLD) are
sparsely studied outside Asia. Objective This prospective study aimed to investigate NAFLD …

Context Obesity is associated with nonalcoholic fatty liver disease (NAFLD). Sleeve
gastrectomy (SG) is an effective means of weight loss and improvement of NAFLD in adults; …

Introduction Over the past two decades, understanding of hepatic macrophage biology has
provided astounding details of their role in the progression and regression of liver diseases …

Purpose Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
in the world. However, biomarkers for NAFLD diagnosis and liver-specific drugs for …